Medicare Advantage ("MA") Trends
Additionally, I view $NURO
as investment in macro trend towards MA, which is where I want my money. NURO serves MA market with DPNCheck. News flow has been strong with the Jun’20 Biomedix announcement and Sep’20 study publication.